212. Tricuspid atresia Disease details / Clinical trials / Drug dev / DR info


Clinical trials : 5 Drugs : 6 - (DrugBank : 6) / Drug target genes : 8 - Drug target pathways : 12

Drugs and their primary sponsors and trial info
Bosentan   
   Rigshospitalet, Denmark
      2011   Phase 2   NCT01292551   Denmark;Sweden;
Dexmedetomidine   
   Athena Zuppa
      2004   Phase 1   NCT00573066   -
Liothyronine I 131   
   FDA Office of Orphan Products Development
      1994   Phase 1   NCT00004828   -
Methacetin Breath Test (MBT)   
   Northwestern University
      2019   -   NCT04176458   United States;
Sildenafil   
   Children's Hospital of Philadelphia
      2007   Phase 2   NCT00507819   United States;
Vitamin C   
   University of Michigan
      2009   -   NCT00974025   United States;